The trademark application Levoiss was filed by Aristo Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on October 24, 2024, and still open for oppositions.
The application was filed in Swedish (German was selected as the second language).